A multicenter, multicohort, phase II study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing metastatic colorectal cancer

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 29; p. ix45
Main Authors	Yoshino, T., Siena, S., Dalal, R., Okuda, Y., Yamamoto, E., Grothey, A.
Format	Journal Article
Language	English
Published	England Elsevier Ltd 01.11.2018
Online Access	Get full text

Loading…

Be the first to leave a comment!